Translation of "Mefenamic acid" in German

Showing prices on Ponstel (active ingredient is Mefenamic Acid).

M$ 18.98 Per pill Ponstel Ponstel (Mefenamic Acid) is indicated for treating pain.

Mefenamic acid should be taken orally after meals.

What are the side effects of Meftal (Mefenamic Acid)?

Mefenamic acid decreases inflammation (swelling) and uterine contractions by a still unknown mechanism.

How should I use Meftal (Mefenamic Acid)?

R 22.46 Per pill Ponstel Ponstel (Mefenamic Acid) is indicated for treating pain.

Ponstel (Mefenamic Acid) is indicated for treating pain.

C$ 2.16 Per pill Ponstel Ponstel (Mefenamic Acid) is indicated for treating pain.

S$ 1.35 Per pill Ponstel Ponstel (Mefenamic Acid) is indicated for treating pain.

What is Meftal (Mefenamic Acid) used for?

Following coadministration of dapagliflozin with mefenamic acid (an inhibitor of UGT1A9), a 55 % increase in dapagliflozin systemic exposure was seen, but with no clinically meaningful effect on 24-hour urinary glucose excretion.

Following coadministration of dapagliflozin with mefenamic acid (an inhibitor of UGT 1A9), a 55% increase in dapagliflozin systemic exposure was seen, but with no clinically meaningful effect on 24-hour urinary glucose excretion.

Following coadministration of dapagliflozin with mefenamic acid (an inhibitor of UGT1A9), a 55% increase in dapagliflozin systemic exposure was seen, but with no clinically meaningful effect on 24-hour urinary glucose excretion.

These include acetylcysteine, acetylsalicylic acid, anipamil×HCl, phenylbutazone, captopril, esuprone, flecainide, nexopamil, nitrofurantoin, (+)-pseudoephedrine×HCl, selegiline×HCl, hydantoins such as 5,5-diphenylhydantoin, benzodiazepines such as diazepam, chlordiazepoxide, pyrazolone derivatives such as diphenylbutazone, aminophenazone, dimethyl-aminophenazone, carbamates such as meprobamate, barbiturates such as phenobarbital, pentobarbital, aminobarbital, antibiotics such as amoxicillin, ciprofloxacin, chloramphenicol, oxytetracyclines, virustatics such as acyclovir, famcyclovir, and antimycotics such as ketoconazole, fluconazole and itraconazole, sulfonamides such as sulfamethoxazole, sulfamoxole, sulfathiazine, steroids such as prednisolone, cyproterone acetate, hydroxyprogesteronecaproate, sulfonamide potentiators such as trimethoprim, non-steroidal antirheumatics (NSAR) such as ibuprofen, diclofenac, mefenamic acid or theophylline.

It is also possible to use less potent analgesics such as anthranilic acid derivatives (flufenamic acid, mefenamic acid), acrylic acid derivatives (diclofenac, tolmetin, zomepirac), arylpropionic acid derivatives (ibuprofen, naproxen, phenoprofen, ketoprofen) and indoleacetic or indenacetic acid derivatives (indometacin, sulindac).

To the inventive pharmaceutical composition concretely belong such compositions that contain as active ingredient or active ingredient mixture, ibuprofene, ketoprofene, naproxene, tolmetine, furabiprofene, a derivative of furapro indomethacine, mefenamic acid, flufenamic acid, paracetamole, acetylsalicylic acid, alclofenac, ketoprofene, ibuprofene, and/or diclofenac-sodium, whereby the first mentioned active ingredients are found, when the inventive composition is supposed to be used as analgetic drug, and the latter mentioned four active ingredients are found in the inventive composition, when the inventive composition is used as an anti-rheumatic drug.

Suitable analgesics are more particularly nonsteroidal analgesics, especially salicylic acid, acetylsalicylic acid and derivatives thereof such as Aspirin®, aniline and its derivatives, acetaminophen, e.g., Paracetamol®, antranilic acid and derivatives thereof, e.g., mefenamic acid, pyrazole or its derivatives, e.g., methamizole, Novalgin®, phenazone, Antipyrin®, isopropylphenazone, and, very preferably, arylacetic acids and their derivatives, heteroarylacetic acids and their derivatives, arylpropionic acids and their derivatives, and herteroarylpropionic acids and also their derivatives, e.g., Indometacin®, Diclophenac®, Ibuprofen®, Naxoprophen®, Indomethacin®, Ketoprofen®, Piroxicam®.

Thus other active substances which may be used for the combinations mentioned above include for example the non-steroidal antiinflammatories aceclofenac, acemetacin, acetylsalicylic acid, azathioprine, diclofenac, diflunisal, fenbufen, fenoprofen, flurbiprofen, ibuprofen, indometacin, ketoprofen, leflunomide, lornoxicam, mefenamic acid, naproxen, phenylbutazone, piroxicam, sulphasalazine, zomepirac or the pharmaceutically acceptable salts thereof as well as meloxicam and other selective COX2-inhibitors, such as for example rofecoxib and celecoxib.

There may be used as active constituent one or more representatives from the group of the analgesics/anti-rheumatics, for example morphine, pethidine, fentanyl, pentazocine, methadone, levacetylmethadol, buprenorphine, nefopam, trodadol, dextropropoxyphene, flupirtine, meptazinol, nalbuphine, tilidine, phenazone, metamizole, propyphenazone, paracetamol, phenylbutazone, mofebutazone, kebuzone, acemetacin, ibuprofen, naproxen, diclofenac, ketoprofen, indomethacin, lonazolac, aceclofenac, mefenamic acid, etofenamate, tiaprofenic acid, azapropazone, lornoxicam, meloxicam, piroxicam, tenoxicam, penicillamine, chloroquine, methotrexate, auranofin, sodium aurothiomalate, oxaceprol, leflunomide, sulphasalazine, celecoxib, rofecoxib, etanercept, sitosterine, hyarulonic acid, flufenamic acid, felbinac, camphor, propyl nicotinate, levomenthol, benzyl nicotinate and/or derivatives thereof and/or pharmaceutically acceptable salts thereof.